'Drug controller impedes hemophilia care in India'

Image
IANS New Delhi
Last Updated : Apr 17 2015 | 10:57 PM IST

Hemophilia care providers on Friday urged India's drug regulator to be more sensitive to their needs and quickly clear the import of medicines donated from abroad.

"DCGI (Drugs Controller General of India0 is not clearing the import of factor (injections) donations we are receiving from the World Federation of Hemophilia (WFH). If this continues, in another 10 days 200 million units will be wasted. We have been facing this difficulty for the past six to seven years," chief executive officer of Hemophilia Federation of India S.S. Roy Choudhury said at an event here on World Hemophilia Day, April 17.

He said the matter was extremely serious and immediate action was required to set things right, adding that donations propel expensive hemophilia care which poor patients cannot afford in India.

Haematologists, hemophilics, relatives and others assembled at the Initiative on Hemophilia Care at the India Habitat Centre here from across the country urged the central government to produce hemophilia medicines and set up coagulations centres and bleeding disorder facilities in each and every hospital across the country.

They also said that centralised procurement of hemophilia medicines by the government helps in reducing the price for the expensive treatment.

Manoj Jhalani, joint secretary, ministry of health and family welfare, said the issues woule be addressed.

"We will certainly take it up on priority," said Jhalani assuring that the assistance from World Federation of Hemophilia should not go waste.

But he said that hemophilia is not as big a public health challenge as diseases like TB, AIDS, cancer and others. "Hemophilia falls lower in terms of public health challenge."

Incidence of hemophilia is 1:10,000 in India and there are an estimated 120,000 patients.

The stakeholders reiterated that numbers must not be considered as the disease is very serious in nature.

BJP MP Meenakshi Lekhi, however, said that she would champion in parliament the cause of hemophilia patients like she highlighted and helped thalassemia patients.

"The humanity which is born with this disorder (hemophilia) needs to be taken care of," said Lekhi. "I will ensure that the message reaches where it has to go."

She said India needs to do work and combine the curative system and preventive system in hemophilia care on the lines of Ayush.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 17 2015 | 10:44 PM IST

Next Story